During the past five years, investing in cannabis stocks has led to dreadful returns for investors. One of the top cannabis ...

Shares of Tilray Brands Inc. TLRY shed 2.50% to $1.17 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.64% to ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/2.iXkfgCgn.js ...

Thank you for joining us for today's conference call to discuss Tilray Brands' financial results for the second quarter ended ...

Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% year ...

Analyst Robert Moskow of TD Cowen maintained a Buy rating on Tilray (TLRY – Research Report), with a price target of $1.50.Stay Ahead of the ...

Tilray hopes that with legalization, it could export medical marijuana to the U.S. and capitalize on its infused beverage ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments. Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net ...

Tilray Brands Inc. closed 59.60% short of its 52-week high of $2.97, which the company reached on April 4th.

Tilray Medical, a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its ...

However, we see little synergies across Tilray's portfolio of cannabis, alcoholic beverages, and wellness products as the markets, distribution systems, and regulatory systems are vastly different.